Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NOX4 pseudogene 1 (NOX4P1) is an annotated pseudogene in the human genome that corresponds to the functional NADPH oxidase 4 (NOX4) gene. Unlike NOX4, which encodes a protein involved in reactive oxygen species production and has defined roles in cell signaling, fibrosis, and cancer, NOX4P1 does not produce a protein and has no described molecular or clinical functions. It is not considered a therapeutic target because it does not participate in protein-mediated biological processes or drug mechanisms[2][4].
None (No mechanisms, as there is no protein product[4])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADPH oxidase 4 pseudogene 1 (NOX4P1).